A step further in understanding the biology of the folate receptor in ovarian carcinoma - PubMed (original) (raw)

Review

. 2003 Jan;88(1 Pt 2):S140-4.

doi: 10.1006/gyno.2002.6705.

Affiliations

• PMID: 12586106
• DOI: 10.1006/gyno.2002.6705

Review

A step further in understanding the biology of the folate receptor in ovarian carcinoma

M Bagnoli et al. Gynecol Oncol. 2003 Jan.

No abstract available

PubMed Disclaimer

Similar articles

• Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression.
  Bagnoli M, Tomassetti A, Figini M, Flati S, Dolo V, Canevari S, Miotti S. Bagnoli M, et al. Oncogene. 2000 Sep 28;19(41):4754-63. doi: 10.1038/sj.onc.1203839. Oncogene. 2000. PMID: 11032026
• Role of folate receptor genes in reproduction and related cancers.
  Elnakat H, Ratnam M. Elnakat H, et al. Front Biosci. 2006 Jan 1;11:506-19. doi: 10.2741/1815. Front Biosci. 2006. PMID: 16146749 Review.
• Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue.
  Markert S, Lassmann S, Gabriel B, Klar M, Werner M, Gitsch G, Kratz F, Hasenburg A. Markert S, et al. Anticancer Res. 2008 Nov-Dec;28(6A):3567-72. Anticancer Res. 2008. PMID: 19189636
• [Prognostic significance of folate binding protein in ovarian neoplasms].
  Toffoli G, Tumolo S. Toffoli G, et al. Tumori. 1999 May-Jun;85(3 Suppl 1):S39-41. Tumori. 1999. PMID: 10542886 Review. Italian. No abstract available.

Cited by

• Immunotherapy Advances for Epithelial Ovarian Cancer.
  Hartnett EG, Knight J, Radolec M, Buckanovich RJ, Edwards RP, Vlad AM. Hartnett EG, et al. Cancers (Basel). 2020 Dec 11;12(12):3733. doi: 10.3390/cancers12123733. Cancers (Basel). 2020. PMID: 33322601 Free PMC article. Review.
• Peptide-Based Vaccines: Current Progress and Future Challenges.
  Malonis RJ, Lai JR, Vergnolle O. Malonis RJ, et al. Chem Rev. 2020 Mar 25;120(6):3210-3229. doi: 10.1021/acs.chemrev.9b00472. Epub 2019 Dec 5. Chem Rev. 2020. PMID: 31804810 Free PMC article. Review.
• FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells.
  Huang MJ, Zhang W, Wang Q, Yang ZJ, Liao SB, Li L. Huang MJ, et al. J Ovarian Res. 2018 Feb 13;11(1):15. doi: 10.1186/s13048-018-0387-y. J Ovarian Res. 2018. PMID: 29433550 Free PMC article.
• Targeting folate receptor alpha for cancer treatment.
  Cheung A, Bax HJ, Josephs DH, Ilieva KM, Pellizzari G, Opzoomer J, Bloomfield J, Fittall M, Grigoriadis A, Figini M, Canevari S, Spicer JF, Tutt AN, Karagiannis SN. Cheung A, et al. Oncotarget. 2016 Aug 9;7(32):52553-52574. doi: 10.18632/oncotarget.9651. Oncotarget. 2016. PMID: 27248175 Free PMC article. Review.
• Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
  Martin SD, Brown SD, Wick DA, Nielsen JS, Kroeger DR, Twumasi-Boateng K, Holt RA, Nelson BH. Martin SD, et al. PLoS One. 2016 May 18;11(5):e0155189. doi: 10.1371/journal.pone.0155189. eCollection 2016. PLoS One. 2016. PMID: 27192170 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information